A recent study has raised concerns about a widely used blood pressure medication called Calcium Channel Blockers (CCBs).

AstraZeneca acquired the hypoparathyroidism therapy eneboparatide as part of a buyout of Amolyt Pharma in July 2024.

Find insights on AstraZeneca, Incyte and more in the latest Market Talks from the health-care sector.

Discover 7 tips to lower high blood pressure naturally, from the DASH diet to stress management techniques that can help you ...

A physician in Chattanooga, Tenn., and his practice in Ringgold, Ga., will pay $700,000 to resolve allegations that they ...

I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from ...

Several months ago, I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from about 50% of the daily value ...

The key secondary efficacy endpoints include normalisation of 24-hour urinary calcium in patients with hypercalciuria ... 6 Eneboparatide has been granted fast track designation and orphan drug ...

Research examines how lectins, oxalates, and phytates in plant foods may impact nutrients and health—balancing benefits ...

Several months ago, I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from about 50% of the daily value ...